The Host Response: A FirstcallID Podcast
How do you choose the “right” antibiotic once cultures are finalized? In this episode of The Host Response, Dr. Paul Bunce walks through one of the most deceptively complex steps in infectious diseases: selecting definitive (or “destination”) antibiotic therapy. While it may feel like the easy part of the case, this decision involves balancing multiple competing factors and not just picking the narrowest drug on the susceptibility report. Considerations include: * Antimicrobial spectrum and when “narrower” isn’t always better * IV vs oral therapy and when PO options are appropriate * Dosing frequency and real-world feasibility * Drug penetration, bioavailability, and site of infection * Drug interactions and toxicity considerations * Patient-specific factors (renal function, comorbidities, pregnancy) * Cost, access, and healthcare system constraints * Why efficacy still matters most — even when we may forget to prioritize it Through practical examples and common clinical dilemmas, this episode highlights why there is often more than one “right” answer, and how to approach these decisions thoughtfully. Whether you’re a trainee or a practicing clinician, this episode will help you build a structured, repeatable approach to antibiotic selection. 🎓 More infectious diseases teaching resources available at FirstCallID.ca
29 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Host Response: A FirstcallID Podcast!